Insider Trading (SEC Form 4)


Insiders are officers, directors, or significant investors. This page shows recent insider transactions for Biological.

Transaction
Date
CompanyInsider Code
(see below)
Shares Post Shares Percent
Change
Share
Price
Tran
Value
Post
Value
Percent
Change
2019-12-29 LPTN H.I.G. Ventures - Endosurgery, LLC ( 10% Owner) J 1,451,185 1,451,185
2019-12-29 LPTN Remeditex Ventures LLC ( 10% Owner) J 1,309,392 1,309,392
2017-11-20 BCLI Rubin Eyal (CFO and Treasurer) A 25,000 25,000
2017-11-17 SGEN DOBMEIER ERIC (Chief Operating Officer) M 10,000 127,424 8.52 26.1 261,000
2017-11-17 SGEN DOBMEIER ERIC (Chief Operating Officer) S -10,000 117,424 -7.85 59.125 -591,250 6,942,694 -8.52
2017-11-17 ATRA Soffer Gad (EVP & Chief Strategy Officer) S -7,000 256,236 -2.66 15.00 -105,000 3,843,540 -2.73
2017-11-16 SGEN DOBMEIER ERIC (Chief Operating Officer) M 6,911 124,335 5.89 26.1 180,377
2017-11-16 SGEN DOBMEIER ERIC (Chief Operating Officer) M 8,489 125,913 7.23 15.46 131,240
2017-11-16 ONCE Webster Stephen W (Chief Financial Officer) M 10,000 12,500 400.00 3.45 34,500
2017-11-16 ONVO Presnell Sharon Collins (Chief Scientific Officer) F -5,860 287,213 -2.00 1.4702 -8,615
2017-11-16 ONVO KUSSMAN CRAIG (Chief Financial Officer) F -11,890 313,748 -3.65 1.4702 -17,481
2017-11-16 ONVO Gallant Paul (General Manager) F -7,015 188,399 -3.59 1.4702 -10,313
2017-11-16 ONVO David Eric (CSO & EVP Pre-Clinical Dev) F -5,625 876,609 -0.64 1.4702 -8,270
2017-11-16 ONVO Bush Jennifer (General Counsel & Secretary) F -8,900 255,180 -3.37 1.4702 -13,085
2017-11-16 SGEN DOBMEIER ERIC (Chief Operating Officer) S -6,911 117,424 -5.56 57.98 -400,700 6,808,244 -5.89
2017-11-16 SGEN DOBMEIER ERIC (Chief Operating Officer) S -8,489 117,424 -6.74 57.95 -491,938 6,804,721 -7.23
2017-11-16 ATRA Clark Mitchall G. (EVP & Chief R & QA Officer) S -3,290 163,052 -1.98 14.20 -46,718 2,315,338 -2.02
2017-11-16 ATRA Gallagher Carol Giltner ( Director) S -1,184 109,738 -1.07 14.20 -16,813 1,558,280 -1.08
2017-11-16 ONCE Webster Stephen W (Chief Financial Officer) S -10,000 2,500 -80.00 70.14 -701,400 175,350 -400.00
2017-11-16 CRIS Rubin Marc ( Director) P 25,000 51,596 94.00 0.98 24,500 50,564 48.45
2017-11-15 NBIX Lippoldt Darin (Chief Legal Officer) M 9,900 23,057 75.25 18.15 179,685
2017-11-15 ATRA Haqq Christopher (EVP, R&D & Chief Scientific Of) M 829 364,134 0.23
2017-11-15 ATRA Ciechanover Isaac E. (Chief Executive Officer Director) M 5,908 1,163,453 0.51
2017-11-15 ATRA Clark Mitchall G. (EVP & Chief R & QA Officer) M 7,212 166,342 4.53
2017-11-15 ATRA Fust Matthew K ( Director) M 1,602 30,503 5.54
2017-11-15 ATRA MCGRATH JOHN (EVP & Chief Financial Officer) M 7,697 128,654 6.36
2017-11-15 ATRA Gallagher Carol Giltner ( Director) M 1,549 110,105 1.43
2017-11-15 ATRA Gallagher Carol Giltner ( Director) M 817 110,922 0.74
2017-11-15 ATRA Soffer Gad (EVP & Chief Strategy Officer) M 4,146 263,236 1.60
2017-11-15 SGEN DOBMEIER ERIC (Chief Operating Officer) M 9,600 127,024 8.18 15.46 148,416
2017-11-15 PRTO NOYES TIMOTHY P (President and CEO Director) D -5,650 28,742 -16.43 1.702 -9,616
2017-11-15 CDTX BIOTECH TARGET N V ( 10% Owner) BB BIOTECH AG ( 10% Owner) P 60,000 2,295,272 2.68 7.5661 453,966 17,366,257 2.61
2017-11-15 SGEN LIPPMAN MARC E ( Director) S -3,000 132,050 -2.22 58.0747 -174,224 7,668,764 -2.27
2017-11-15 SGEN DOBMEIER ERIC (Chief Operating Officer) S -9,600 117,424 -7.56 57.7955 -554,837 6,786,579 -8.18
2017-11-15 ATRA Haqq Christopher (EVP, R&D & Chief Scientific Of) S -1,604 362,530 -0.44 13.36 -21,429 4,843,401 -0.44
2017-11-15 RGNX Vasista Vittal (Chief Financial Officer) S -5,000 87,283 -5.42 25.30 -126,500 2,208,260 -5.73
2017-11-15 NBIX Lippoldt Darin (Chief Legal Officer) S -9,900 13,157 -42.94 73.0496 -723,191 961,114 -75.25
2017-11-15 CRIS Fattaey Ali Ph.D. (President & CEO Director) P 50,000 115,890 75.88 1.06 53,000 122,843 43.14
2017-11-14 PRTO NOYES TIMOTHY P (President and CEO Director) D -4,350 34,392 -11.23 1.687 -7,338
2017-11-14 PRTO BOHLIN GAREN G ( Director) A 3,812 53,312 7.70 1.889 7,201
2017-11-14 ATRA Ciechanover Isaac E. (Chief Executive Officer Director) S -2,200 1,157,545 -0.19 13.41 -29,502 15,522,678 -0.19
2017-11-14 PRTO Eldridge, George Arthur (Sr VP, CFO, Treasr, Asst Secy) P 295 14,295 2.11 1.69 499 24,159 2.06
2017-11-13 ONCE Marrazzo Jeffrey D (Chief Executive Officer Director) M 20,000 250,000 8.70 3.45 69,000
2017-11-13 ONCE La Barge Joseph (Chief Legal Officer) M 2,191 11,025 24.80 3.45 7,559
2017-11-13 GILD MILLIGAN JOHN F (President and CEO Director) M 220,000 1,385,924 18.87 21.575 4,746,500
2017-11-13 NSTG GHESQUIERE DAVID W. (SVP, Corporate & Business Dev) M 2,500 17,327 16.86
2017-11-13 PRTO BOHLIN GAREN G ( Director) A 25,700 49,500 107.98 1.918 49,293
2017-11-13 GILD MILLIGAN JOHN F (President and CEO Director) S -220,000 1,165,924 -15.87 72.8849 -16,034,678 84,978,254 -18.87
2017-11-13 ONCE Marrazzo Jeffrey D (Chief Executive Officer Director) S -20,000 230,000 -8.00 71.54 -1,430,800 16,454,200 -8.70
2017-11-13 ATRA Ciechanover Isaac E. (Chief Executive Officer Director) S -2,200 1,159,745 -0.19 13.53 -29,766 15,691,350 -0.19
A
Grant, award, or other acquisition of securities from the company (such as an option)
K
Equity swaps and similar hedging transactions
P
Purchase of securities on an exchange or from another person
S
Sale of securities on an exchange or to another person
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
M
Exercise or conversion of derivative security received from the company (such as an option)
G
Gift of securities by or to the insider
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)